INSIGHTS ON DRUG DEVELOPMENT
-
![Five Practical Considerations To Move From Concept To Clinic]( "Five Practical Considerations To Move From Concept To Clinic")
Five Practical Considerations To Move From Concept To ClinicLearn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.
-
![Organ-On-A-Chip]( "What Are Organ-Chips?")
What Are Organ-Chips?Learn in detail about Organ-on-a-Chip technology and how it is paving the way for the next generation of drug development and research.
-
![GettyImages-2160715091 lab analysis]( "Bioanalytical Quantification Of A Biotherapeutic Peptide")
Bioanalytical Quantification Of A Biotherapeutic PeptideDiscover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.
-
![GettyImages-2213157127-drug-formulation-discovery-pipette-liquid-vial]( "How One Biotech Company Is Accelerating The Drug Discovery Workflow")
How One Biotech Company Is Accelerating The Drug Discovery WorkflowSee how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.
-
Efficient Stem Cell Expansion In Bioreactors For Immunotherapy12/9/2025
A scalable bioreactor process enables efficient expansion of cord blood-derived HSCs and NK cell differentiation, delivering high purity and strong cytotoxicity, advancing immune cell therapies.
-
The Future Of Preclinical Animal Models In Drug Discovery5/10/2024
The paradigm shift from animal to human Organ-Chips in preclinical research offers promising insights and efficiencies, crucial for advancing drug development and reducing human suffering.
-
Development Of Separation Methods for GLP-1 Synthetic Peptides6/27/2025
Peptides offer precise, low-cost therapeutic potential, especially in GLP-1 drugs for diabetes and weight loss. A new HPLC-UV/MS method ensures consistent quality and analysis of these compounds.
-
CDMOs - Key Collaborators In Streamlining Drug Development12/12/2025
Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.
-
A Checklist For Efficient And Reliable Gene Therapy Manufacturing6/3/2024
Gain insight into how to design and execute an efficient upstream AAV production process, and follow the checklist within to ensure all appropriate factors are considered at each phase of drug development.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-1027587952-nurse-doctor-patient-comfort]( "Molecule To Cure. Fast.")
Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.
-
![Bench-Top Syringe Cartridge Closing System]( "Pharmaceutical Bench-Top Filling & Closing Machines: GENiSYS® Lab")
AST’s line of table-top machines, GENiSYS® Lab, are ideal systems for drug product development and cGMP production applications. Each system is designed to automate the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. These table-top systems are engineered to have complete compatibility with cleanroom environments, including Laminar Air Flow Hoods, Bio-Safety Cabinets and aseptic isolators.
-
![Asahi Kasei - 450x300_IBF]( "The Buyer's Guide To Buffer Formulation Equipment")
Purchasing buffer formulation equipment involves more than just price. Explore critical features, budget considerations, and vendor qualifications to secure a reliable system that meets your needs.
-
![Alliance iS HPLC System]( "Intuitively Simple HPLC System")
This intuitive and reliable HPLC system supports First Time Quality (FTQ) by reducing the risk of common errors and improving the accuracy of analytical measurements.
-
![Nanoform]( "GMP Manufacturing")
Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards.
